Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide

BACKGROUND: Chimeric antigen receptors (CARs) presented on T cell surfaces enable redirection of T cell specificity, which has enormous promise in antitumor therapy. However, excessive activity and poor control over such engineered T cells cause significant safety challenges, such as cytokine releas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Hematol Oncol
Asıl Yazarlar: Zhang, Erhao, Gu, Jieyi, Xue, Jianpeng, Lin, Chenyu, Liu, Chen, Li, Mengwei, Hao, Jingchao, Setrerrahmane, Sarra, Chi, Xiaowei, Qi, Weiyan, Hu, Jialiang, Xu, Hanmei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859748/
https://ncbi.nlm.nih.gov/pubmed/29558951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0591-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller